Department of Health Policy

Distinguished visitor

Rahul Gupta, MD, MPH, MBA, director of National Drug Control Policy visited Vanderbilt last week to learn about the Medical Center’s efforts related to child-maternal addiction care, the Firefly program and Team Hope.

Hospital readmissions tied to supply of nearby care options: study

Vanderbilt research finds that hospitals’ 30-day readmission rates were lower if they had a larger supply of primary care physicians, nursing homes or palliative care services nearby.

Insurance claims for gender-affirming therapies have increased, but filling prescriptions without insurance may be more affordable, new study finds

Vanderbilt researchers found that both gender dysphoria diagnoses and use of gender therapies have increased substantially between 2013 and 2019.

Filling multiple opioid prescriptions after childbirth associated with maternal death risk

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.

New study illustrates how much it would cost for cancer drugs covered under Medicare Part D

A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.

Medicare beneficiaries without low-income subsidies were less likely to fill important prescriptions, new study finds

Vanderbilt research shows that Medicare Part D beneficiaries who did not receive federal subsidies to lower their out-of-pocket costs were nearly twice as likely as others to not fill prescriptions for serious health conditions like cancer or hepatitis C treatment.

1 2 3 4 5 13